Sep30Mon

Thank you to our renewing members

Thank you to our members who continue to support the Chamber through their membership, you make our mission possible!

Renewing members in September:

Mid-Size Firm Members
GREYHAWK, Ron Kerins and Jay Appleton
StreamLine Payroll, Brian Tierney and Patty Duffy
Cal OpEx, John Cummins and Ross Lane

Individual Members
Lisa Maloney, Berkadia
Daniel Horan, Planet Fitness
Michael McCourt, BB&T Bank
Joseph O’Drain, Withum Smith & Brown, PC
Timothy Hillert, BenXchange
Joseph McGrath, Consulting
Ed Waters, Island Networks
Robert Hart, AB Bernstein

 

Sep26Thu

Member News from the Museum of the American Revolution

American Revolution museum’s new ‘Irish Soldier’ exhibit has it all: Love. Death. Psychodrama.
The Philadelphia Inquirer
by Stephan Salisbury

R. Scott Stephenson, president and chief executive of the Museum of the American Revolution, calls the Cost of Revolution: The Life and Death of an Irish Soldier, a “psychological thriller of museum exhibits.”

Curator Matthew Skic, who put the ambitious show together for the museum, is a little less dramatic. He says, “It speaks to the trans-Atlantic impact of the American Revolution. What happens here, what happens here in Philadelphia, matters on a global scale.”

Click HERE to read more.

Sep26Thu

Member News from Almac Group

Almac’s unique gene expression report enables cancer researchers to discover exciting new insights claraT report now includes all ten Hallmarks of Cancer to aid novel Biomarker Discovery

Craigavon, N.I., 26 September 2019 – Almac Diagnostic Services, a member of the Almac Group, will launch the complete version of claraT at the ESMO Congress in Barcelona on 27th September. The Almac claraT Total mRNA Report content has expanded considerably from the initial version launched the previous year at the ESMO Congress. The complete version now includes 92 gene expression signatures, 100 single gene drug targets and over 7,000 additional biology linked genes, categorised by all 10 Hallmarks of Cancer.

Read More

Sep25Wed

Member News from Almac Group

Almac Pharma Services Achieves Unprecedented Global Regulatory Milestone
Three successful regulatory inspections completed in two weeks

Craigavon, U.K., 25 Sep 2019 Almac Pharma Services, part of the global contract pharmaceutical development and manufacturing organisation, the Almac Group, has announced the successful completion of three global regulatory GMP inspections across three facilities in the space of just two weeks.

The UK MHRA conducted a routine GMP audit at the company’s Charnwood, UK facility. The 230,000ft2 site, based in Loughborough, was acquired by Almac in 2015 and provides GMP development and manufacturing of solid oral dose clinical trial materials and small scale commercial volumes. The three day inspection of the site’s quality systems resulted in no critical or major findings.

Read More